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Real-Time MRI-Guided Catheter 
Tracking Using Hyperpolarized 
Silicon Particles
Nicholas Whiting1,*, Jingzhe Hu1,2,*, Jay V. Shah1,3, Maja C. Cassidy4, Erik Cressman5, 
Niki Zacharias Millward1, David G. Menter6, Charles M. Marcus7 & Pratip K. Bhattacharya1
Visualizing the movement of angiocatheters during endovascular interventions is typically 
accomplished using x-ray fluoroscopy. There are many potential advantages to developing magnetic 
resonance imaging-based approaches that will allow three-dimensional imaging of the tissue/
vasculature interface while monitoring other physiologically-relevant criteria, without exposing the 
patient or clinician team to ionizing radiation. Here we introduce a proof-of-concept development of 
a magnetic resonance imaging-guided catheter tracking method that utilizes hyperpolarized silicon 
particles. The increased signal of the silicon particles is generated via low-temperature, solid-state 
dynamic nuclear polarization, and the particles retain their enhanced signal for ≥40 minutes—
allowing imaging experiments over extended time durations. The particles are affixed to the tip of 
standard medical-grade catheters and are used to track passage under set distal and temporal points 
in phantoms and live mouse models. With continued development, this method has the potential 
to supplement x-ray fluoroscopy and other MRI-guided catheter tracking methods as a zero-
background, positive contrast agent that does not require ionizing radiation.
In the United States, heart disease has been the leading cause of death for nearly a century1, with recent 
annual death tolls of approximately 600,000 people2 and direct and indirect costs exceeding $100 billion3 
per annum. Cardiovascular diagnostic and interventional methodologies require the use of endovascular 
catheterization for procedures such as angiography, angioplasty, ablation, stent placement, and valve 
repair. Furthermore, catheters are also frequently used in risk stratification of chemotherapy-induced 
cardiotoxicity4 and embolization therapy of cancer patients5. Critical tracking of these catheters is typ-
ically accomplished by monitoring a radiopaque filler material embedded into the polymer walls of 
catheters using x-ray fluoroscopy6; this cardiovascular guidance approach allows for real-time feedback, 
high spatiotemporal resolution, and the ability to distinguish the position of the catheter relative to ana-
tomical structures. However, x-ray fluoroscopy-guided catheter tracking suffers from limitations in soft 
tissue contrast, as well as difficulty in three-dimensional navigation6. To some extent, this is addressed 
using cone-beam CT image reconstruction, but with the added costs of increased radiation exposure and 
decreased soft tissue contrast. In the clinic, this technique typically requires refresh rates of 1–10 frames 
per second (FPS); these refresh rates, combined with procedure-related activities, can expose both the 
patient (direct exposure in the short term) and attending physician and team (scatter exposure over the 
long term) to ionizing radiation in a relatively short period of time (minutes to tens of minutes). This 
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can be especially problematic for pediatric patients7, who not only have a much longer anticipated life-
time but also a greater potential for multiple procedures. Additional health concerns in patients that are 
attributed to the iodinated contrast media include nephropathy8 and, less commonly, allergic reactions.
Magnetic resonance imaging (MRI)-guided catheter tracking is attractive due to its many potential 
benefits, including three-dimensional imaging of the interactions between soft tissues and the vascu-
lature without using ionizing radiation. The use of MRI-based catheter guidance also allows clinicians 
to simultaneously monitor other physiologically-relevant criteria, including metabolism, temperature, 
blood flow velocity, and tissue perfusion9. To date, typical MRI-guided catheter guidance approaches fall 
into one of two categories: active or passive tracking. The former method involves monitoring the active 
signal of a miniature radiofrequency (rf) coil placed near the catheter tip10, while the latter may examine 
susceptibility differences between paramagnetic dysprosium oxide rings embedded into the catheter ver-
sus that of nearby tissue11. Other passive MR catheter tracking techniques include T1-weighted imaging 
of a catheter filled with gadolinium12, or non 1H-imaging of catheters filled with other contrast media 
(including 19F imaging of perfluorooctylbromide13 and 13C imaging of hyperpolarized (HP) 13C-labelled 
2-hydroxyethylpropionate14). While these methods offer contrast between the otherwise MR-invisible 
catheter and patient anatomy, they also suffer from inherent drawbacks that limit their applicability in 
the clinic. For example, active catheter tracking methods require specialized catheters and dedicated 
rf circuitry/equipment, while posing the risk of localized tissue heating and steering problems due to 
the inflexibility of the catheter tip10. While passive susceptibility tracking is a relatively simple process 
by comparison to active imaging, it usually provides negative contrast that is vulnerable to distortion 
artefacts11 and also requires the use of a specialized catheter. T1-weighted imaging of gadolinium-filled 
catheters requires competition with a significant 1H noise background and T2*-associated signal losses12. 
In the case of hyperpolarized 13C tracer alternatives, a continuous supply of the contrast agent is required 
because these tracers naturally depolarize within a timeframe of 60 seconds, an effect that is hastened by 
magnetization-depleting rf pulses during signal acquisition14 (a consequence that is true for all hyper-
polarized media). Also, catheters that are filled with liquid MRI contrast agents (such as gadolinium 
or 19F and 13C tracers) cannot easily be used for simultaneously injecting other liquids into the body13 
without employing multi-lumen catheters, thereby limiting their clinical use for further diagnostic and/
or interventional procedures.
A method of hyperpolarizing silicon micro- and nanoparticles has been recently demonstrated15,16 
to increase 29Si MR signals by up to 3–5 orders of magnitude via enhanced nuclear spin alignment, 
while retaining this improved signal for tens of minutes. Hyperpolarization of the 29Si nuclear spins is 
generated by solid-state dynamic nuclear polarization (DNP), which uses low temperatures and high 
magnetic fields to spin-polarize an electron bath to near unity; this spin polarization is then transferred 
to nearby nuclear spins through microwave-mediated dipolar interactions17. DNP of solid (dry) silicon 
particles takes advantage of naturally-occurring electronic defects on the particle surfaces and obviates 
the need for additional radicals to generate the necessary free electrons18. The resulting increase in 29Si 
nuclear spin polarization is relatively long-lasting (T1 ~ 40 minutes)15 compared to other hyperpolarized 
modalities (e.g., HP 13C tracers)19, and is not affected by the in vivo environment. Silicon micro- and 
nanoparticles are non-toxic, non-radioactive, and have been investigated for biomedical applications due 
to their favorable biocompatibility and biodegradability20.
Here, we use solid-state hyperpolarized silicon particles as a proof-of-concept for MRI-based catheter 
guidance in both phantoms and in vivo. We demonstrate catheter tracking both over long time durations 
(40 minutes) and in real time (refresh rate of 6.25 FPS), as well as two-dimensional and three-dimensional 
catheter guidance visualization. This method of passive catheter tracking provides background-free pos-
itive contrast using a standard medical-grade catheter and does not require the catheter to be filled 
with a liquid tracer. The biocompatible silicon particles are commercially available and would contrib-
ute minimally to the cost of the procedure (the work presented here required ~3¢ of silicon particles), 
and are hyperpolarized using a well-characterized21 modality that has recently been made available for 
clinical studies of 13C-labeled metabolic tracers22. With further development, this approach could have a 
situational clinical role as a non-ionizing, zero-background, positive contrast imaging agent for real-time 
catheter guidance using MRI.
Results
Catheter tracking over long time durations. Silicon particles (average mean diameter ~ 2 μ m) 
were packed into sample tubes and hyperpolarized in the solid state using a home-built DNP device. 
Following hyperpolarization, the particles were collected, quickly warmed to room temperature, and 
affixed to the tip of a medical grade catheter. For this study, two silicon samples were used: ~50 mg of 
particles loaded onto a 24 Fr urinary catheter (8 mm outer diameter, or ‘OD’), and ~6 mg of particles 
loaded onto a 5 Fr angiocatheter (1.67 mm OD). Additional experimental criteria are available in the 
Materials and Methods section, as well as the Supplementary Material.
As an initial proof-of-concept, Fig. 1a shows positive contrast 29Si images (co-registered with 1H imag-
ing) of the urinary catheter transiting ~4 cm through a gelatin phantom over the course of 40 minutes; 
this short distance is necessitated by the use of a 29Si/1H dual-tuned MRI coil that was designed for in 
vivo mouse studies (active region of coil only 52 mm in z-axis). The extended time scale over which the 
particles retain their increased magnetization is consistent with previous silicon micro- and nanoparticle 
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studies15,23, and is far greater than what is typically expected from other hyperpolarized species (e.g., T1 
of HP 13C-labelled tracers is typically ≤1 minute)24. The ability to acquire images over this time duration 
supports this method’s future development for potential utility in the clinic.
Multi-dimensional catheter tracking. Following the initial catheter tracking demonstration using 
a large urinary catheter, we progressed to monitoring a medical-grade angiocatheter using roughly 
an order of magnitude fewer particles (corresponding to ~12% of the previously available magnetiza-
tion). This 5 Fr catheter was tracked in two dimensions at distinct points over the course of ~4 cm and 
28 minutes as it transited through a plastic Y-shaped hollow phantom to simulate guidance through the 
branching of the vasculature (specifically, for typical retrograde common femoral artery access with the 
catheter tip positioned above the level of the simulated aortic bifurcation; Fig. 1b). Further visualization 
of angiocatheter maneuverability includes three-dimensional tracking through a spiral-shaped phantom 
(Fig. 1c; Supplemental Video S1).
In vivo catheter tracking. Given that the 5 Fr angiocatheter is similar in diameter to commercially 
available endoscopes used for mouse colonoscopies25 as well as being a common size for human endovas-
cular use, initial in vivo studies were carried out using the large intestine of a live mouse as a surrogate 
Figure 1. HP 29Si particle MRI-tracking in phantoms. (a) Transit of ~50 mg of silicon particles loaded 
into a 24 Fr urinary catheter moving ~4 cm through a gelatin phantom over the course of 40 minutes; co-
registered 29Si/1H imaging shows the outline of the catheter in the void space left in the gelatin.  
(b) Angiocatheter (5 Fr) loaded with ~6 mg of silicon particles moving through Y-shaped hollow plastic 
phantom to simulate branching of vasculature; picture of catheter and phantom superimposed with a 
composite of 29Si MRI images. The sample tube containing silicon particles is push-fit onto the tip of the 
angiocatheter. (c) Angiocatheter tracking three-dimensional passage around a spiral phantom (picture 
inset). Absolute 29Si signal intensities (colored scale, arbitrary units) are consistent for (a)–(c); greyscale 
denotes 1H intensities. Pertinent imaging parameters, as well as Supplemental Video S1 (showing a rotating 
view of Fig. 1c), are included in the Supplementary Materials.
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for the human vasculature. The 5 Fr angiocatheter, loaded with silicon particles, was inserted into the 
rectum of a normal mouse and a series of 29Si imaging acquisitions was executed at discrete intervals 
while the catheter transited through the intestinal tract (Fig.  2; Supplemental Video S2; Supplemental 
Fig. S1). Following this series, a single 1H image was taken for anatomical co-registration; because the 1H 
image was acquired following the catheter movement, there is a slight discrepancy in the overlaid images 
due to a catheter-induced shifting of the large intestines, along with potential peristaltic responses by the 
gut that are not present in the single 1H scan. Subsequent studies utilized an alternating 29Si/1H imaging 
protocol (Fig. 3; Supplemental Video S3) that shows the undulating of the intestines with the movement 
of the catheter. Regardless, the catheter is visualized moving in two dimensions ~3 cm through the intes-
tinal tract of the mouse over the course of ~4 minutes (~2 cm in 22 min. for Fig. 3), demonstrating the 
first in vivo results using HP 29Si particles for catheter guidance.
Real-time catheter tracking. Because continuous imaging is requisite for catheter tracking in the 
clinic, we demonstrated this technique using real-time 29Si imaging of the urinary catheter transiting 
through a gelatin phantom (Fig.  4; Supplemental Video S4). The co-registered images show the cathe-
ter moving ~5 cm over the course of 20 frames in ~3.2 seconds (only 11 of the 20 frames shown here), 
resulting in a frame rate of 6.25 FPS. These image refresh rates are comparable to those that are typically 
achieved using fluoroscopy-guided catheter tracking in the clinic6. Longer time durations of continuous 
imaging are also possible using the same allotment of hyperpolarized particles (as the experiment was 
successfully repeated immediately afterwards with the same sample; not shown).
Discussion
In this proof-of-concept study, we have demonstrated the viability of passive catheter tracking using 
hyperpolarized 29Si MRI using both phantoms and mouse models, over long time durations and in 
real time, and in both two and three dimensions. This method provides radiation-free, background-free 
positive contrast over the course of > 40 minutes using non-specialized catheters that are tagged with a 
biologically safe media. While current limitations in 29Si polarization level, MR hardware, and MR pulse 
sequences did not allow for real-time imaging (of several FPS) over the course of minutes, this advance 
will be critical to potential future clinical translation. With further development, co-registered 1H/29Si 
MRI may find a role in clinical catheter tracking because of its ability to image the tissue/vasculature 
interface, as well as track other physiologically-relevant criteria. Compared to other MRI-guided catheter 
imaging techniques, it is not susceptible to rf burns, negative contrast, distortion artefacts, or competitive 
background signals.
The experiments presented here are limited by a reduced field of view that is inherent to small animal 
imaging coils that are designed for mouse imaging (35 mm inner diameter, or ‘ID’; 52 mm homogenous rf 
region in z-axis); this is a result of the 29Si DNP polarizer being situated in a small animal imaging facility 
Figure 2. HP 29Si particle MRI-tracking in vivo. Composite of 29Si images (co-registered with single 1H 
anatomical scan) showing transit of angiocatheter loaded with silicon particles through the large intestines 
of a live normal mouse (picture inset) over the course of 4 min. Absolute 29Si signal intensities are denoted in 
arbitrary units on the colored scale; greyscale denotes 1H intensities. Pertinent imaging parameters, as well 
as Supplemental Video S2 (showing a time-lapse video of the catheter tracking in Fig. 2), are included in the 
Supplementary Materials.
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without any clinical scanners in close proximity. Combined with this is a current lack of human-scale 
MRI detection coils that are tuned to the 29Si resonance frequency. Another potential drawback is the 
non-renewable nature of hyperpolarized signal; which decays through both natural spin population 
redistribution over time, as well as through the application of magnetization-depleting rf pulses for image 
acquisition. The 29Si signal in these particles can last for tens of minutes, which is on the same scale as 
most endovascular catheterization procedures. Also, the depletion of available magnetization upon the 
administration of rf pulses was mitigated by using small tipping angle pulses to minimally perturb the 
29Si spins. For early acquisitions, a Fast Low-Angle Shot (FLASH) sequence employed a ramped tip-
ping angle to provide near-constant 29Si signal intensities with each acquisition; the final image of the 
longer time duration experiments ended with a 90° Rapid Acquisition with Refocused Echos (RARE) 
sequence to maximize the amount of signal left at the end of the study. Given the short T2* of these 
silicon particles (~600 ms), additional gains could be achieved by employing a zero echo time (ZTE) 
imaging sequence to improve the signal-to-noise ratio with even smaller excitation pulses; it should also 
be noted that 29Si MRI scans were completed with single scans (no averaging required) and use high 
reconstruction thresholding due to zero 29Si signal background and a priori knowledge of the expected 
image profile. Furthermore, the long T2 (1–2 s) of these could be taken advantage of in order to image 
more lines of k-space with fewer rf pulses, and future improvements to the imaging hardware (i.e., flexi-
ble phased-array coils) can also be used to maximize scanning time by mitigating the deleterious effects 
of image acquisition. With moderate improvements to the 29Si hyperpolarization level, MR hardware, 
and pulse sequences, the spatial resolution in this study (~1 mm) may become more competitive with 
the current clinical standard of x-ray fluoroscopy (~0.1 mm).
Silicon-based micro- and nanoparticles have received recent interest as targeted diagnostic and drug 
delivery vehicles, due to their biocompatibility, biodegradability, and simple surface chemistry that is 
amenable to drug loading and targeting20. Because of this, they are favorable for development as platform 
nanotechnologies, where multiple targeting agents and therapeutic drugs can be attached to the particles 
surfaces for multiplexed theranostic applications. For this study, we chose larger silicon microparticles 
Figure 3. Co-registered 29Si/1H MRI-tracking in vivo. Transit of angiocatheter through the large intestines 
of a live normal mouse using alternating 29Si/1H scans, showing changes in mouse anatomy with movement 
of the catheter. Absolute 29Si signal intensities are denoted in arbitrary units on the colored scale; greyscale 
denotes 1H intensities. Pertinent imaging parameters, as well as Supplemental Video S3 (showing a time-
lapse video of the catheter tracking in Fig. 3), are included in the Supplementary Materials.
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because of their longer T1 compared to particles in the < 100 nm range (T1 ~ 10–15 min). The ability to 
hyperpolarize these particles makes them amenable to in vivo MR imaging15; since its gyromagnetic 
ratio is similar to those of 13C and 15N, the 29Si resonance frequency is typically within the tuning range 
of commercial (multinuclear) MRI systems. Increasing interest in clinical 29Si MRI may prompt the 
implementation of human-scale imaging coils that are resonant at the 29Si precession frequency; these 
coils may be able to improve on relative sensitivity (neglecting filling factor) using phased-array receiver 
configurations. Future studies will look to utilize clinical MRI scanners and torso 29Si imaging coils to 
expand the available field of view for catheter tracking.
The recent clinical demonstration of DNP of small 13C-metabolites22 in prostate cancer patients, along 
with ongoing clinical trials of silicon-based particles for drug delivery26, should help pave the way for rapid 
translation of hyperpolarized 29Si MRI to the clinic. Although current versions of commercially-available 
clinical DNP devices are not marketed for silicon hyperpolarization, there should be no technical reason 
why it would not be feasible with minor alterations; in the future, using these devices for both 13C met-
abolic studies and 29Si molecular and interventional imaging could help defray hospital costs for access 
to hyperpolarized media. Furthermore, because the effects of hyperpolarization are field-independent, 
this technique is amenable for MRI at lower B0, as well as in open-configuration scanners that are more 
conducive to interventional procedures. For this proof-of-concept work, the sample tube of hyperpolar-
ized silicon particles was either push-fit onto the end of the angiocatheter, or placed inside the end of the 
urinary catheter; while we did not physically alter the catheter in any way, we recognize that improve-
ments in silicon particle placement will be key to further development. To that end, future studies will 
attempt to coat the entirety of the catheter in hyperpolarized silicon particles to permit visualization of 
Figure 4. Real-time 29Si MRI catheter tracking. Individual scans showing movement of the large urinary 
catheter through a gelatin phantom at a frame rate of 6.25 FPS; bottom right figure shows composite of all 
twenty 29Si images (not all shown individually) over the course of 3.2 seconds. Co-registered with a single 
1H scan (greyscale) after conclusion of 29Si images (colored scale). Inset picture shows silicon particles 
inside polarizing tube next to urinary catheter and gelatin phantom; during the experiment, the sample 
tube containing the silicon particles is placed inside the urinary catheter (utilizing the existing port near the 
catheter tip, not shown), where it rests between the two red horizontal lines drawn on the catheter. Pertinent 
imaging parameters, as well as Supplemental Video S4 (showing a real-time video of the catheter tracking in 
Fig. 4), are included in the Supplementary Materials.
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the full catheter length (allowing bends and/or kinks to be monitored) while allowing the lumen to be 
used to inject contrast media, collect specimens, and conduct interventional operations and therapies. 
With further development, enhanced 29Si MRI-guided catheter visualization may allow clinicians to per-
form concurrent diagnostic and interventional MRI studies without the need to shuttle patients from one 
imaging suite to another, decreasing patient residence time and increasing safety.
Materials and Methods
29Si particles and catheters. Silicon particles (polycrystalline/amorphous; average mean diame-
ter ~2 μ m) were commercially sourced (CAS No. 7440-21-3) and used as received (99.9985% elemental 
purity; 29Si isotopic natural abundance of ~4.7%). The particles were packed into small Teflon tubes; one 
sample (used for phantom experiments) contained ~50 mg of particles packed into a 3 mm ID × 8 mm 
long tube and (following 29Si DNP) was placed inside the existing opening near the tip of the large uri-
nary catheter (24 Fr; 8 mm OD; Rochester Medical Corp.), while the other sample (used for phantom 
and mouse experiments) consisted of ~6 mg of particles packed into a 1.4 mm ID × 4.5 mm long tube 
and (following DNP) was push-fit onto the tip of the angiocatheter (5 Fr; 1.67 mm OD; Cook Medical). 
For hyperpolarization, the sample tubes were push-fit onto the end of a garolite rod and inserted into 
the DNP device (the smaller sample was placed inside of a larger sample tube, which was then push-fit 
onto the end of the garolite rod).
29Si DNP. After insertion of the packed sample tubes into the home-build polarizer, DNP was per-
formed at ~ 3.2 K and ~2.9 T. Polarization times typically ranged from 5 hours for the larger (50 mg) 
sample to 17 hours for the smaller (6 mg) sample; the deciding factor for polarization time was the 
ability to generate sufficient 29Si signal to complete the imaging study (these silicon particles typically 
reached steady-state hyperpolarization after ~15 hrs of DNP). The 100 mW microwave source was 
frequency-modulated from 80.83 to 80.90 GHz using a 20 kHz ramp modulation, and directed to the 
sample via waveguide and slot antenna. Quality control was monitored using an on-board miniature 
NMR spectrometer to sample 29Si polarization levels during DNP. The silicon particles can be quickly 
removed from the polarizer, warmed to room temperature, and affixed to the catheter tip without a sig-
nificant loss in polarization; the low specific heat capacity (712 J/kg°C) and robust thermal conductivity 
(159 W/m°C) of silicon27 allow the sample to be warmed by hand while transporting to the MRI scanner 
(Ttransport < 1 minute). The measured hyperpolarized relaxation rate of the silicon particles was ~25 min-
utes at 7 T and room temperature.
MRI experiments. All imaging experiments described here were performed in a 7 T horizontal-bore 
small animal scanner (Bruker Biospin), using Paravision software (v5.1; Bruker Biospin). A custom-made 
dual-tuned 1H/29Si litz coil (Doty Scientific) was used for co-registered imaging (35 mm ID; homogenous 
rf region ~52 mm along z-axis). A small sample of silicon oil (1.5 ml; CAS: 63148-62-9) was used for 
calibration purposes; typical 29Si nuclear spin polarization values ranged from 0.5–1.0%. 29Si imaging was 
performed using Fast Low Angle Shot (FLASH) and Rapid Acquisition with Refocused Echoes (RARE) 
sequences; 1H anatomical and phantom images used a RARE sequence in the coronal plane. Additional 
details of the imaging sequences and processing protocols are listed in the Supplementary Materials.
Phantom experiments. Phantoms were positioned in the center of the homogenous rf region of the 
MRI coil, and the HP 29Si -tagged catheter was moved through the phantom during imaging acquisi-
tions. Phantoms consisted of gelatin inside a 50 ml centrifuge tube (Figs 1a and 4), a 3-way plastic hose 
barb connector (Fig.  1b), and a spiral groove etched into the side of a 32 mm diameter × 98 mm long 
cylindrical stock of PTFE (Fig. 1c).
Mouse handling. All animal studies were performed in accordance with animal use protocols that 
were approved by the UT MD Anderson Cancer Center “Institutional Animal Care and Use Committee” 
(IACUC). Wild type male APC(+/+) mice with a BL6 background (DOB 12/25/2013; sourced from MD 
Anderson Cancer Center) were used in all studies; these non-genetically modified mice (tail genotyping) 
were produced in an APCMIN breeding colony. These normal mice were anesthetized with 2% isoflurane 
(in 0.75 l/min oxygen) administered by an MR-compatible nose cone while the mouse was stationed on 
a custom cradle inside the MRI coil. The HP 29Si -tagged 5 Fr angiocatheter was inserted ~3 cm into the 
rectum of the live mouse; it was then slowly pulled out in discrete intervals corresponding to the given 
imaging sequence. For Fig. 2; a single 1H image was acquired after the series of 29Si images. For Fig. 3, 
alternating 29Si and 1H images were acquired. All mice survived the procedure with no evidence of ill 
effects.
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